Quantcast

Tag: Gene therapy

placeholder

GENEVA — Swiss pharmaceuticals giant Novartis says it has agreed to buy the U.S.-based gene therapy company AveXis Inc. for $8.7 billion, part of...

STAY CONNECTED

1FansLike
4,407FollowersFollow